130 related articles for article (PubMed ID: 1875338)
1. Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties.
Bovy PR; Collins JT; Olins GM; McMahon EG; Hutton WC
J Med Chem; 1991 Aug; 34(8):2410-4. PubMed ID: 1875338
[TBL] [Abstract][Full Text] [Related]
2. Central and peripheral actions of a nonpeptidic angiotensin II receptor antagonist.
Koepke JP; Bovy PR; McMahon EG; Olins GM; Reitz DB; Salles KS; Schuh JR; Trapani AJ; Blaine EH
Hypertension; 1990 Jun; 15(6 Pt 2):841-7. PubMed ID: 2190928
[TBL] [Abstract][Full Text] [Related]
3. Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives.
Bühlmayer P; Criscione L; Fuhrer W; Furet P; de Gasparo M; Stutz S; Whitebread S
J Med Chem; 1991 Oct; 34(10):3105-14. PubMed ID: 1920360
[TBL] [Abstract][Full Text] [Related]
4. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
7. 4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists.
Norman MH; Smith HD; Andrews CW; Tang FL; Cowan CL; Steffen RP
J Med Chem; 1995 Nov; 38(23):4670-8. PubMed ID: 7473594
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.
Carini DJ; Duncia JV; Aldrich PE; Chiu AT; Johnson AL; Pierce ME; Price WA; Santella JB; Wells GJ; Wexler RR
J Med Chem; 1991 Aug; 34(8):2525-47. PubMed ID: 1875348
[TBL] [Abstract][Full Text] [Related]
9. Evidence that [Sar1]angiotensin II behaves differently from angiotensin II at angiotensin AT1 receptors in rabbit aorta.
Liu YJ
Eur J Pharmacol; 1993 Apr; 235(1):9-15. PubMed ID: 8519284
[TBL] [Abstract][Full Text] [Related]
10. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
[TBL] [Abstract][Full Text] [Related]
11. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
[TBL] [Abstract][Full Text] [Related]
12. Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites.
Bensoussan M; Mitchell T; Reilly T; Timmermans PB; Verroust PJ; Ronco PM
Eur J Pharmacol; 1993 Oct; 247(2):169-75. PubMed ID: 8282006
[TBL] [Abstract][Full Text] [Related]
13. Antagonist effect of losartan on angiotensin II induced contraction in five isolated smooth muscle assays.
Liu YJ
Eur J Pharmacol; 1993 Aug; 240(2-3):147-54. PubMed ID: 8243534
[TBL] [Abstract][Full Text] [Related]
14. Nonpeptide angiotensin II receptor antagonists: synthetic and computational chemistry of N-[[4-[2-(2H-tetrazol-5-yl)-1-cycloalken-1- yl]phenyl]methyl]imidazole derivatives and their in vitro activity.
Lin HS; Rampersaud AA; Zimmerman K; Steinberg MI; Boyd DB
J Med Chem; 1992 Jul; 35(14):2658-67. PubMed ID: 1635064
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.
Ashton WT; Hutchins SM; Greenlee WJ; Doss GA; Chang RS; Lotti VJ; Faust KA; Chen TB; Zingaro GJ; Kivlighn SD
J Med Chem; 1993 Nov; 36(23):3595-605. PubMed ID: 8246227
[TBL] [Abstract][Full Text] [Related]
16. Preliminary biochemical characterization of two angiotensin II receptor subtypes.
Whitebread S; Mele M; Kamber B; de Gasparo M
Biochem Biophys Res Commun; 1989 Aug; 163(1):284-91. PubMed ID: 2775266
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720).
Deprez P; Guillaume J; Becker R; Corbier A; Didierlaurent S; Fortin M; Frechet D; Hamon G; Heckmann B; Heitsch H
J Med Chem; 1995 Jun; 38(13):2357-77. PubMed ID: 7608902
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.
Bovy PR; Reitz DB; Collins JT; Chamberlain TS; Olins GM; Corpus VM; McMahon EG; Palomo MA; Koepke JP; Smits GJ
J Med Chem; 1993 Jan; 36(1):101-10. PubMed ID: 8421274
[TBL] [Abstract][Full Text] [Related]
19. 1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists.
Weinstock J; Keenan RM; Samanen J; Hempel J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Gleason JG; Hill DT
J Med Chem; 1991 Apr; 34(4):1514-7. PubMed ID: 2016730
[No Abstract] [Full Text] [Related]
20. The conformation and activity relationship of fused analogs of DuP753.
Yoo SE; Shin YA; Lee SH; Kim NJ
Bioorg Med Chem; 1995 Mar; 3(3):289-95. PubMed ID: 7606390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
